Apoptosis - the p53 network
暂无分享,去创建一个
Michael Berger | Y. Haupt | S. Haupt | M. Berger | Zehavit Goldberg | Zehavit Goldberg | Ygal Haupt | Susan Haupt
[1] A. Strasser,et al. BH3-Only Proteins—Essential Initiators of Apoptotic Cell Death , 2000, Cell.
[2] K. Vousden,et al. PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.
[3] K. Helin,et al. Apaf-1 is a transcriptional target for E2F and p53 , 2001, Nature Cell Biology.
[4] Yuxin Yin,et al. PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression , 2003, Nature.
[5] Diane Sears,et al. Life-and-death decisions. , 1985, The Washington post.
[6] S. Korsmeyer,et al. Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[7] T. Burns,et al. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo , 2001, Oncogene.
[8] Moshe Oren,et al. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis , 2002, Oncogene.
[9] V. Skulachev. Cytochrome c in the apoptotic and antioxidant cascades , 1998, FEBS letters.
[10] H. Ding,et al. Oncogene-dependent Regulation of Caspase Activation by p53 Protein in a Cell-free System* , 1998, The Journal of Biological Chemistry.
[11] C. Harris,et al. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. , 2001, Cancer research.
[12] B. Foster,et al. Pharmacological rescue of mutant p53 conformation and function. , 1999, Science.
[13] J. Beckmann,et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.
[14] G. E. Davis,et al. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis , 2001, Apoptosis.
[15] S. Korsmeyer,et al. Damage-induced apoptosis in intestinal epithelia from bcl-2-null and bax-null mice: investigations of the mechanistic determinants of epithelial apoptosis in vivo , 1999, Oncogene.
[16] Joanna K. Sax,et al. BID regulation by p53 contributes to chemosensitivity , 2002, Nature Cell Biology.
[17] J. Massagué,et al. Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage , 2002, Nature.
[18] A. Levine,et al. The p53 functional circuit. , 2001, Journal of cell science.
[19] C. Bergeron,et al. Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer’s Disease* , 1999, The Journal of Biological Chemistry.
[20] Petr Pancoska,et al. p53 has a direct apoptogenic role at the mitochondria. , 2003, Molecular cell.
[21] M. Oren,et al. Regulation of p53: intricate loops and delicate balances. , 2002, Biochemical pharmacology.
[22] Y. Seo,et al. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. Gottlieb. A Fly with an Ointment: Bcl-2 as an Anti-Mutator in Humans , 2002, Cancer biology & therapy.
[24] R. Iggo,et al. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Strasser,et al. CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types. , 2000, Cancer research.
[26] R. Dickson,et al. Overexpression of c-Myc Alters G1/S Arrest following Ionizing Radiation , 2002, Molecular and Cellular Biology.
[27] M. Lohrum,et al. Regulation and activation of p53 and its family members , 1999, Cell Death and Differentiation.
[28] S. Nagata,et al. The Fas death factor , 1995, Science.
[29] J P Luzio,et al. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. , 1998, Science.
[30] Keisuke Kuida,et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome , 2002, Nature.
[31] M. Muzio. Signalling by proteolysis: death receptors induce apoptosis , 1998, International journal of clinical & laboratory research.
[32] T. Taniguchi,et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. , 2000, Science.
[33] A. Strasser,et al. BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. , 2002, Journal of cell science.
[34] I. Mian,et al. SATB1 Cleavage by Caspase 6 Disrupts PDZ Domain-Mediated Dimerization, Causing Detachment from Chromatin Early in T-Cell Apoptosis , 2001, Molecular and Cellular Biology.
[35] S. Korsmeyer,et al. bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[36] K. Kinzler,et al. Definition of a consensus binding site for p53 , 1992, Nature Genetics.
[37] M. Pincus,et al. Conformational and Molecular Basis for Induction of Apoptosis by a p53 C-terminal Peptide in Human Cancer Cells* , 1999, The Journal of Biological Chemistry.
[38] Moshe Oren,et al. Regulation of p53: intricate loops and delicate balances. , 2002, Biochemical pharmacology.
[39] W. El-Deiry,et al. Apoptotic threshold is lowered by p53 transactivation of caspase-6 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. Givol,et al. A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1 , 2002, Oncogene.
[41] A. Kimchi,et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.
[42] A. Gudkov. Converting p53 from a killer into a healer , 2002, Nature Medicine.
[43] K. Vousden,et al. Activation and activities of the p53 tumour suppressor protein , 2001, British Journal of Cancer.
[44] A. Fersht,et al. Rescuing the function of mutant p53 , 2001, Nature Reviews Cancer.
[45] S. Cory,et al. Apoptosomes: engines for caspase activation. , 2002, Current opinion in cell biology.
[46] S. Lowe,et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. , 1999, Science.
[47] D. Israeli,et al. p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs , 1998, The Journal of experimental medicine.
[48] K. Kinzler,et al. A model for p53-induced apoptosis , 1997, Nature.
[49] L. Post. Selectively replicating adenoviruses for cancer therapy: an update on clinical development. , 2002, Current opinion in investigational drugs.
[50] Galina Selivanova,et al. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound , 2002, Nature Medicine.
[51] Tong-Yuan Yang,et al. Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer , 2003, Cancer Gene Therapy.
[52] E. Shaulian,et al. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. , 1995, Genes & development.
[53] A. Giaccia,et al. The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.
[54] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[55] B. Groner,et al. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain , 1997, Nature Medicine.
[56] E. May,et al. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice , 2000, Oncogene.
[57] M. Eilers,et al. Negative regulation of the mammalian UV response by Myc through association with Miz-1. , 2002, Molecular cell.
[58] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[59] Mason R. Mackey,et al. Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane , 2002, Cell.
[60] Junying Yuan,et al. Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.
[61] Alfonso Bellacosa,et al. AKT plays a central role in tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[62] K. Tsai,et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage , 2002, Nature.
[63] Y. Shaul. c-Abl: activation and nuclear targets , 2000, Cell Death and Differentiation.
[64] S. Korsmeyer,et al. Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death* , 1999, The Journal of Biological Chemistry.
[65] Judith Roth,et al. A polymorphic microsatellite that mediates induction of PIG3 by p53 , 2002, Nature Genetics.
[66] N D Marchenko,et al. Death Signal-induced Localization of p53 Protein to Mitochondria , 2000, The Journal of Biological Chemistry.
[67] K. Wiman,et al. Reactivation of Mutant p53 through Interaction of a C-Terminal Peptide with the Core Domain , 1999, Molecular and Cellular Biology.
[68] C. Thompson,et al. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. , 1998, Trends in cell biology.
[69] Martin L. Smith,et al. Chemotherapeutic Targeting of p53 , 2002, Cancer biology & therapy.
[70] K. Kinzler,et al. PUMA mediates the apoptotic response to p53 in colorectal cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[71] S. Lowe,et al. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. , 2000, Genes & development.
[72] C. Prives,et al. p53 leans on its siblings. , 2002, Cancer cell.
[73] W. El-Deiry,et al. The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis , 2002, Cancer biology & therapy.
[74] M. Karin,et al. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.
[75] I. Krantz,et al. KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene , 1997, Nature Genetics.
[76] Xin Lu,et al. ASPP proteins specifically stimulate the apoptotic function of p53. , 2001, Molecular cell.
[77] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[78] J. Levine,et al. Surfing the p53 network , 2000, Nature.
[79] S. Cory,et al. The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.
[80] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[81] Gideon Rechavi,et al. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1 , 2001, Oncogene.
[82] G. Wahl,et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. , 2002, Molecular cell.
[83] A. Neri,et al. Restoration of the transcription activation function to mutant p53 in human cancer cells. , 1996, Oncogene.
[84] A. Fersht,et al. A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutants , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[85] K. Kinzler,et al. PUMA induces the rapid apoptosis of colorectal cancer cells. , 2001, Molecular cell.
[86] K. A. McKenna,et al. p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta. , 1997, Cancer research.
[87] J. Manfredi,et al. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes , 2002, Oncogene.
[88] L. Mayo,et al. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. , 2002, Trends in biochemical sciences.
[89] Jiri Bartek,et al. Cell-cycle checkpoints and cancer , 2004, Nature.
[90] Ronit Vogt Sionov,et al. The cellular response to p53: the decision between life and death , 1999, Oncogene.
[91] T. Jacks,et al. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2 , 1994, Cell.
[92] L. Latonen,et al. Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277. , 2002, Nucleic acids research.
[93] D R Alessi,et al. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? , 2001, Journal of cell science.
[94] W. El-Deiry,et al. Stabilization of p53 by CP-31398 Inhibits Ubiquitination without Altering Phosphorylation at Serine 15 or 20 or MDM2 Binding , 2003, Molecular and Cellular Biology.
[95] Gang Li,et al. The p53 stabilizing compound CP-31398 induces apoptosis by activating the intrinsic Bax/mitochondrial/caspase-9 pathway. , 2002, Experimental cell research.